Is there an ectopic secretion of monomeric calcitonin in the human being?

被引:11
作者
Engelbach, R
Heerdt, S
Görges, R
Kunt, T
Pfützner, A
Forst, T
Diefenbach, K
Walgenbach, S
Beyer, J
机构
[1] Univ Mainz Klinikum, Dept Internal Med & Endocrinol, D-55131 Mainz, Germany
[2] Univ Mainz Klinikum, Dept Nucl Med, D-55131 Mainz, Germany
[3] Univ Mainz Klinikum, Dept Surg, D-55131 Mainz, Germany
关键词
calcitonin; thyroidectomy; ectopic production; differentiated thyroid carcinoma; follow-up;
D O I
10.1007/s004230050160
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction: Persistent detectable calcitonin (CT) values can be frequently observed after treatment of medullary thyroid carcinomas (MTCs). Apart from residual C cells or incomplete tumor extirpation, ectopic CT production should be taken into account. CT determination in patients without MTC and after total thyroidectomy should reveal to what extent, apart from the C cells, other neuroendocrine cells show a relevant CT production. Objectives: The objective of this study was to find out whether ectopic CT production can be detected using an assay specifically recognizing the monomeric form of CT. Methods: The CT serum values were obtained from 94 healthy individuals and 64 patients who had undergone total thyroidectomy and radioiodine therapy because of follicular or papillary carcinoma. Results: In the group of thyroidectomized patients, the CT values were below the detection limit of the assay. In the tested patients, there was neither a physiological (C cell) nor a pathological (MTC cell) secretion of monomeric CT. Conclusion: A relevant ectopic monomeric CT production could be excluded because the patients were without detectable CT concentration. For this reason, postoperative CT concentrations of the monomeric form in MTC patients can be traced either to remaining C cells or to tumor cells. For a differentiation of these two possibilities further diagnostics is necessary.
引用
收藏
页码:456 / 459
页数:4
相关论文
共 26 条
[1]   CALCITONIN IN EXTRA-THYROIDAL TISSUES OF MAN [J].
BECKER, KL ;
SNIDER, RH ;
MOORE, CF ;
MONAGHAN, KG ;
SILVA, OL .
ACTA ENDOCRINOLOGICA, 1979, 92 (04) :746-751
[2]   CALCITONIN IN TISSUES OF THYROIDECTOMIZED MONKEY [J].
BECKER, KL ;
GEELHOED, G ;
ONEILL, W ;
MONAGHAN, KG ;
SNIDER, RH ;
MOORE, CF ;
SILVA, OL .
EXPERIENTIA, 1980, 36 (05) :609-610
[3]   CALCITONIN HETEROGENEITY IN LUNG-CANCER AND MEDULLARY-THYROID CANCER [J].
BECKER, KL ;
SNIDER, RH ;
SILVA, OL ;
MOORE, CF .
ACTA ENDOCRINOLOGICA, 1978, 89 (01) :89-99
[4]   ESTIMATES OF CIRCULATING MONOMERIC CALCITONIN - PHYSIOLOGICAL-STUDIES IN NORMAL AND THYROIDECTOMIZED MAN [J].
BODY, JJ ;
HEATH, H .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 57 (05) :897-903
[5]   CALCITONIN DEFICIENCY AFTER RADIOACTIVE IODINE TREATMENT [J].
BODY, JJ ;
DEMEESTERMIRKINE, N ;
CORVILAIN, J .
ANNALS OF INTERNAL MEDICINE, 1988, 109 (07) :590-591
[6]  
FALK SA, 1988, ARCH OTOLARYNGOL, V114, P168
[7]  
GALANTE L, 1968, LANCET, V2, P537
[8]  
GHILLANI PP, 1989, CANCER RES, V49, P6845
[9]   BONE-DENSITY AND MINERAL METABOLISM IN THYROIDECTOMIZED PATIENTS TREATED WITH LONG-TERM L-THYROXINE [J].
GIANNINI, S ;
NOBILE, M ;
SARTORI, L ;
BINOTTO, P ;
CIUFFREDA, M ;
GEMO, G ;
PELIZZO, MR ;
DANGELO, A ;
CREPALDI, G .
CLINICAL SCIENCE, 1994, 87 (05) :593-597
[10]  
LAX SF, 1994, VIRCHOWS ARCH, V424, P441